CN102266392A - Rhinitis patch - Google Patents
Rhinitis patch Download PDFInfo
- Publication number
- CN102266392A CN102266392A CN2011102182570A CN201110218257A CN102266392A CN 102266392 A CN102266392 A CN 102266392A CN 2011102182570 A CN2011102182570 A CN 2011102182570A CN 201110218257 A CN201110218257 A CN 201110218257A CN 102266392 A CN102266392 A CN 102266392A
- Authority
- CN
- China
- Prior art keywords
- rhinitis
- carboxymethyl starch
- glycerol
- oil
- oleum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a rhinitis patch, which comprises sodium carboxymethyl starch, water, eucalyptus essential oil, lavender oil, peppermint oil and glycerol in a certain ratio. The rhinitis patch is prepared by the following steps of: dissolving the sodium carboxymethyl starch in water; adding the eucalyptus essential oil, the lavender oil, the peppermint oil and he glycerol and uniformly mixing; and smearing the mixture onto non-weaving cloth to obtain the rhinitis patch which can be attached to a nose bridge. The rhinitis patch has a good effect and quick response, is convenient to carry, is free from any untoward reaction, and is suitable for various uncomfortable symptoms such as rhinitis, nasosinusitis, and nasal obstruction, rhinocnesmus, dizziness and the like caused by cold.
Description
Technical field
The present invention relates to a kind of medical supplies of nasal cavity, be specifically related to a kind of Ointment for nasitis, belong to medical technical field.
Background technology
Rhinitis is meant that bronchia mucosal and mucosa undertissue owing to the inflammation that the infection that is subjected to virus, antibacterial, anaphylactogen causes, show as hyperemia or edema, and the patient nasal obstruction occurs through regular meeting; rhinocnesmus, throat's discomfort, cough; symptoms such as snivel are a kind of relatively more obstinate commonly encountered diseases.
The sickness rate of rhinitis is and obviously increases trend, and its sickness rate is 10～20% according to statistics, and the sickness rate of rhinitis is especially with annual 3～5% speed increment in recent years.The medical circle analysis and research are the result show: the upgrading of environmental pollution and the decline of air quality are the immediate causes that causes the rhinitis sickness rate to increase.Be suspended in toxic gas such as motor vehicle exhaust emission thing in the environment that we depend on for existence, incineration of garbage thing, commercial production Litter, and each bacterioid, dust etc., all the time all enter in the nasal cavity in breathing with people, in case have an opportunity, these nuisances will grow in the nasal cavity gathering, cause inflammation.The people must breathe, and one breathes, and virus, antibacterial, anaphylactogen will enter with breathing, under the safeguard procedures protection without any correspondence, must cause rhinitis, even can show effect repeatedly.
Rhinitis is divided into usually: acute rhinitis, chronic simple rhinitis, chronic hypertrophic rhinitis, rhinitis sicca, atrophic rhinitis, caseous rhinitis, allergic rhinitis, medicamentous rhinitis etc.The Therapeutic Method of rhinitis has naturopathy, Drug therapy, operative treatment etc., adopts simple physics or Drug therapy, DeGrain, and treatment cycle is long, easily recurrence; And the employing operative treatment, its expense height has the risk that produces the postoperative sequela.
Summary of the invention
For the method that solves existing treatment rhinitis adopts physics or Drug therapy merely, DeGrain, easily recurrence, and the expenses of surgical treatment height, the problems such as risk that produce the postoperative sequela are arranged, the invention provides a kind of Ointment for nasitis, the method that adopts naturopathy and Drug therapy to combine reaches the purpose of treatment, makes the rhinitis patient reach good therapeutic effect.
The present invention realizes by following technical proposal: a kind of Ointment for nasitis is characterized in that being made up of following component by mass percent:
Carboxymethyl starch sodium 10～40%
Eucalyptus quintessence oil 0.05～5%
Oleum lavandula angustifolia 0.05～5%
Oleum menthae 0.05～5%
Glycerol 5～30%
Water surplus.
Described carboxymethyl starch sodium, eucalyptus quintessence oil, Oleum menthae, Oleum lavandula angustifolia, glycerol are commercial product.
When preparing Ointment for nasitis of the present invention, get material, carboxymethyl starch sodium is added in the entry dissolve by said ratio, add eucalyptus quintessence oil, Oleum menthae, Oleum lavandula angustifolia and glycerol again, mix homogeneously is applied in mixture on the non-weaving cloth in right amount, promptly gets Ointment for nasitis.
During use, the horizontal bridge of the nose place that is affixed on gets final product with the powder of gained Ointment for nasitis, and one pasted 12 hours, pastes 2 every day and pastes, and pasting with three days continuously is a course of treatment.
Advantage of the present invention and effect: adopt such scheme, the physics effectiveness and the Drug therapy of product are played a role together, promptly based on hydrophilic carboxymethyl starch sodium gel, cooperate the drug action of eucalyptus quintessence oil, Oleum menthae, Oleum lavandula angustifolia and glycerol, by contacting of drug gel face and skin of bridge of nose, make eucalyptus quintessence oil, Essential lavender oil, Herba Menthae wet goods active substance, directly absorbed, thereby reach therapeutic purposes by lesions position.Hydrophilic carboxymethyl starch sodium gel plays the effect of physics cold compress simultaneously, edema, congested inflammation are eased, therefore better than adopting single naturopathy or medication effect, and be difficult for recurrence, clinical this product of use treatment acute rhinitis, can cure in general three days, and with existing rhinitis tablet or BIYANKANG sheet oral medication, generally need take medicine a week just can have apparent in view effect.In addition, the present invention also have carry, extremely easy to use, rapid-action, advantage such as have no adverse reaction.Applied range of the present invention be applicable to malaise symptoms such as nasal obstruction that various rhinitis, sinusitis and flu cause, rhinocnesmus, giddy, and this product adopts advanced technology prescription, can bring convenience and better therapeutic effect for vast rhinitis patient.
The specific embodiment
Below by embodiment the present invention is described further.
Embodiment 1
Get carboxymethyl starch sodium 100g, water 800g, eucalyptus quintessence oil 20 g, Oleum lavandula angustifolia 20g, Oleum menthae 10g and glycerol 50g, carboxymethyl starch sodium added in the entry dissolve, add eucalyptus quintessence oil, Oleum menthae, Oleum lavandula angustifolia and glycerol again and carry out mix homogeneously, formulated Ointment for nasitis.
Embodiment 2
Get carboxymethyl starch sodium 200g, water 600g, eucalyptus quintessence oil 30g, Oleum lavandula angustifolia 10g, Oleum menthae 10g and glycerol 150g, carboxymethyl starch sodium added in the entry dissolve, add eucalyptus quintessence oil, Oleum menthae, Oleum lavandula angustifolia and glycerol again and carry out mix homogeneously, formulated Ointment for nasitis.
Embodiment 3
Get carboxymethyl starch sodium 400g, water 400g, eucalyptus quintessence oil 0.5g, Oleum lavandula angustifolia 0.5g, Oleum menthae 0.5g and glycerol 198.5g, carboxymethyl starch sodium added in the entry dissolve, add eucalyptus quintessence oil, Oleum menthae, Oleum lavandula angustifolia and glycerol again and carry out mix homogeneously, formulated Ointment for nasitis.
Embodiment 4
Get carboxymethyl starch sodium 300g, water 400g, eucalyptus quintessence oil 15g, Oleum lavandula angustifolia 15g, Oleum menthae 20g and glycerol 250g, carboxymethyl starch sodium added in the entry dissolve, add eucalyptus quintessence oil, Oleum menthae, Oleum lavandula angustifolia and glycerol again and carry out mix homogeneously, formulated Ointment for nasitis.
Embodiment 5
Get carboxymethyl starch sodium 150g, water 700g, eucalyptus quintessence oil 50 g, Oleum lavandula angustifolia 20g, Oleum menthae 10g and glycerol 70g, carboxymethyl starch sodium added in the entry dissolve, add eucalyptus quintessence oil, Oleum menthae, Oleum lavandula angustifolia and glycerol again and carry out mix homogeneously, formulated Ointment for nasitis.
Embodiment 6
Get carboxymethyl starch sodium 350g, water 450g, eucalyptus quintessence oil 5g, Oleum lavandula angustifolia 40g, Oleum menthae 5g and glycerol 150g, carboxymethyl starch sodium added in the entry dissolve, add eucalyptus quintessence oil, Oleum menthae, Oleum lavandula angustifolia and glycerol again and carry out mix homogeneously, formulated Ointment for nasitis.
Embodiment 7
Get carboxymethyl starch sodium 100g, water 450g, eucalyptus quintessence oil 50g, Oleum lavandula angustifolia 50 g, Peppermint Oil 50 g and glycerol 300g, carboxymethyl starch sodium added in the entry dissolve, add eucalyptus quintessence oil, Oleum menthae, Oleum lavandula angustifolia and glycerol again and carry out mix homogeneously, formulated Ointment for nasitis.
For showing effect of the present invention, the present invention is through clinical observation, and the result is as follows:
One, data and method
Yunnan Province hospitals of traditional Chinese and western medicine department of eye is used patient's 36 examples such as nasitis plaster treatment acute rhinitis provided by the invention, chronic simple rhinitis, atrophic rhinitis, obtains better curative effect.Now be reported as follows:
1, physical data
This group is totally 36 examples, wherein male 20 examples, women 16 examples; 30 years old～56 years old age, average 38 years old; Treatment acute rhinitis 15 examples, chronic simple rhinitis 12 examples; Atrophic rhinitis's 9 examples.
Clinical manifestation: 20 examples of having a stuffy nose; Rhinorrhea 10 examples; Band blood 17 examples in the tears; Women's head-ornaments portion pain 15 examples; Blow slag specimen frowziness chip or agglomerate 7 examples.All cases do not have symptoms such as paroxysmal sneeze, a large amount of thin nasal discharge of stream and asthma.The intranasal mirror is checked down: congested swelling 16 examples of nasal mucosa; The middle nasal meatus has purulent secretion 15 examples; Lark or pitchy bean dregs sample thing 10 examples are arranged at the bottom of middle nasal meatus or the nose; Inside bulge 1 example of lateral wall of nasal cavity.CT examination: 1. the hole chamber changes, and the pathological changes nasal sinuses is the shadow filling person of density unevenness soft-tissue density 16 examples wholly or in part; Soft-tissue density's shadow filling and be dispersed in irregular speckle shape calcification kitchen range person 25 examples in the hole all intends being diagnosed as rhinitis.2. the maxillary sinus inwall absorbs saboteur 16 examples, and sieve parietal bone wall absorbs saboteur 10 examples.Pathological tissues carries out pathologic finding and sees that more inflammatory exudate is arranged in the mucous membrane tissue.
2. Therapeutic Method
With the horizontal bridge of the nose place that is affixed on of gel face, each pasted with 12 hours with embodiment 3 gained Ointment for nasitis, pasted 2 every day and pasted continued treatment three days.
3, observational technique
Nasal endoscopy after three days.
Two, result
After the treatment, through nasal endoscopy, nasal cavity, nasal sinuses are clean, and Dou Kou is open good, no purulent secretion, the every transference cure of patient.This organizes 36 routine symptom complete obiterations, follows up a case by regular visits to for 1～May, and patient there is no recurrence.
Three, conclusion
This clinical test results shows: the rhinitis of external is posted in the nasal obstruction alleviating and eliminate acute rhinitis, chronic simple rhinitis, atrophic rhinitis and cause, rhinocnesmus, rhinorrhea, the tears and is with blood, women's head-ornaments portion pain, blows slag specimen frowziness chip or malaise symptoms such as agglomerate, giddy.
Claims (1)
1. Ointment for nasitis is characterized in that being made up of following component by mass percent:
Carboxymethyl starch sodium 10～40%
Eucalyptus quintessence oil 0.05～5%
Oleum lavandula angustifolia 0.05～5%
Oleum menthae 0.05～5%
Glycerol 5～30%
Water surplus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110218257 CN102266392B (en) | 2011-08-01 | 2011-08-01 | Rhinitis patch |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110218257 CN102266392B (en) | 2011-08-01 | 2011-08-01 | Rhinitis patch |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102266392A true CN102266392A (en) | 2011-12-07 |
| CN102266392B CN102266392B (en) | 2013-04-10 |
Family
ID=45048976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110218257 Expired - Fee Related CN102266392B (en) | 2011-08-01 | 2011-08-01 | Rhinitis patch |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102266392B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103191184A (en) * | 2013-04-16 | 2013-07-10 | 王怀伟 | Novel nasal strip gel layer, novel nasal strip and preparation method of nasal strip |
| CN104056347A (en) * | 2014-06-04 | 2014-09-24 | 赵冬艳 | Medical mask and application method thereof |
| CN105168362A (en) * | 2015-09-24 | 2015-12-23 | 江门市新时代外用制剂有限公司 | Breatheasy patch and preparation method thereof |
| CN106420936A (en) * | 2016-09-20 | 2017-02-22 | 紫花（广州）药业有限公司 | Refreshing essential oil containing lavender extract |
| CN107617033A (en) * | 2017-10-19 | 2018-01-23 | 广州金御化妆品有限公司 | Alleviate the uncomfortable You Jiali massage creams of children respiratory |
| CN111821368A (en) * | 2019-04-19 | 2020-10-27 | 鼻精灵(重庆)医疗科技有限公司 | Composition for treating rhinitis and rhinitis ointment containing composition |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1634349A (en) * | 2004-11-04 | 2005-07-06 | 上海交通大学 | Incense fumigating agent for coryza |
| CN101524325A (en) * | 2009-04-03 | 2009-09-09 | 龚志成 | Compound menthol microemulsion and preparation for nose |
-
2011
- 2011-08-01 CN CN 201110218257 patent/CN102266392B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1634349A (en) * | 2004-11-04 | 2005-07-06 | 上海交通大学 | Incense fumigating agent for coryza |
| CN101524325A (en) * | 2009-04-03 | 2009-09-09 | 龚志成 | Compound menthol microemulsion and preparation for nose |
Non-Patent Citations (3)
| Title |
|---|
| 傅冠民: "芳香疗法的由来、作用及其应用", 《香料香精化妆品》 * |
| 刘淑英: "细述精油情趣", 《科学之友》 * |
| 国家药品监督管理局: "《国家中成药标准汇编（耳鼻喉科、眼科、皮肤科分册）》", 31 December 2002 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103191184A (en) * | 2013-04-16 | 2013-07-10 | 王怀伟 | Novel nasal strip gel layer, novel nasal strip and preparation method of nasal strip |
| CN103191184B (en) * | 2013-04-16 | 2015-01-14 | 王怀伟 | Novel nasal strip gel layer, novel nasal strip and preparation method of nasal strip |
| CN104056347A (en) * | 2014-06-04 | 2014-09-24 | 赵冬艳 | Medical mask and application method thereof |
| CN105168362A (en) * | 2015-09-24 | 2015-12-23 | 江门市新时代外用制剂有限公司 | Breatheasy patch and preparation method thereof |
| CN106420936A (en) * | 2016-09-20 | 2017-02-22 | 紫花（广州）药业有限公司 | Refreshing essential oil containing lavender extract |
| CN107617033A (en) * | 2017-10-19 | 2018-01-23 | 广州金御化妆品有限公司 | Alleviate the uncomfortable You Jiali massage creams of children respiratory |
| CN111821368A (en) * | 2019-04-19 | 2020-10-27 | 鼻精灵(重庆)医疗科技有限公司 | Composition for treating rhinitis and rhinitis ointment containing composition |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102266392B (en) | 2013-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102266392B (en) | Rhinitis patch | |
| KR101337578B1 (en) | Mucoadhesive xyloglucan―containing formulations useful in medical devices and in pharmaceutical formulations | |
| CN102198126B (en) | Liniment for treating mouth and tooth diseases and applicator | |
| CN102258574B (en) | Chinese medicinal preparation for treating allergic rhinitis | |
| CN105663243A (en) | Traditional Chinese medicinal composition for treating rhinitis and/or nasosinusitis and drug of traditional Chinese medicinal composition | |
| CN101590107B (en) | Rhinitis ointment | |
| CN101040829B (en) | Novel application of Yunnan Baiyao medicine | |
| JP2008255089A (en) | Epithelium improving agent | |
| CN103263525A (en) | Gynecological cleaning fluid and preparation method thereof | |
| CN104258455B (en) | A kind of medical bio antiseptic dressing and preparation method thereof | |
| CN108366991B (en) | Synergistic compound of pyrrolidone carboxylic acid and/or salts thereof and hyaluronic acid and/or salts thereof for the treatment and/or prevention of dryness and irritation of mucous membranes, and related pharmaceutical formulations | |
| CN110179843B (en) | External-use pharmaceutical composition for treating non-allergic rhinitis | |
| CN101199615A (en) | External and internal administration disintegrating tablets for treating oral ulcer and preparing method thereof | |
| CN110151786A (en) | Application and the drug of the nano carbon particle in the drug of preparation treatment canker sore | |
| CN102274250B (en) | External patch Chinese medicine for treating phthisis and preparation method thereof | |
| CN106138254A (en) | A kind of preparation method and applications of antiphlogistic bezoar buccal tablet | |
| CN104055921B (en) | A kind of pharmaceutical composition and application thereof for the treatment of oral lichen planus | |
| CN105853614A (en) | Gynaecological capsule | |
| CN101152216A (en) | Traditional Chinese medicine for treating chronic suppurative otitis media | |
| CN105125708A (en) | Pharmaceutical composition for treating rhinitis and preparation method thereof | |
| CN108926657A (en) | A kind of preparation and application of graphene precious jade medicine nasitis plaster | |
| CN101978968B (en) | Medicament for treating tympanitis | |
| CN103585460B (en) | A kind of tamping for gingiva hemostasis | |
| CN103463236B (en) | Medicinal composition and preparation method thereof | |
| CN101919799B (en) | Novel sustained-release transdermal medicament delivery system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130410 Termination date: 20170801 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |